An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity.
about
P1343
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamideAndrogen Receptor: A Complex Therapeutic Target for Breast CancerIκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptorExpression of androgen receptor splice variants in clinical breast cancers.Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer.Postmenopausal breast cancer, androgens, and aromatase inhibitors.The role of the androgen receptor in triple-negative breast cancer.Transcriptional regulation of human UDP-glucuronosyltransferase genes.Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.Differential expression and androgen regulation of microRNAs and metalloprotease 13 in breast cancer cells.A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.Wild-type and specific mutant androgen receptor mediates transcription via 17β-estradiol in sex hormone-sensitive cancer cells.Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.The Androgen Receptor in Breast Cancer
P2860
Q21195191-34B3D835-5CC8-45E8-8686-51080BE4F3CBQ28075188-52CC07BF-E13A-4803-B0E1-8BEE6A144685Q35933129-AA7E92D8-4935-45E4-A95B-8E4E1771324FQ36689084-2D5E59CA-153E-433B-95A6-F7D8ADCD403DQ37077443-45CEAD33-A131-4FB9-A964-B446CD4CED87Q38097730-B74F4131-8D31-4A91-9D29-5F852FAAFB3EQ38119251-FF39AEC6-64BD-412A-8A1D-9E6580C82381Q38261875-4324FC41-8F0F-435C-A221-F273DF061001Q38399495-F2E4B2CC-D29B-4E65-86AB-0EE5521F816AQ38552128-34F796CF-BDEB-4954-A4F8-01E561DF8430Q38620609-2981237F-581D-45CE-80A8-95238A7F8A4EQ38766156-B5A50A3A-49B2-4B52-AF6E-A6AFBAB4D9ABQ38925848-5F987208-3B8D-46EE-BAEE-954E5B31A688Q42514809-238F453E-82E5-452E-9DD3-F25D6CDE17E1Q57107469-D94B43BE-BF02-4329-8D59-999BE88E42F1
P2860
An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
An androgen receptor mutation ...... compromises receptor activity.
@en
An androgen receptor mutation ...... compromises receptor activity.
@nl
type
label
An androgen receptor mutation ...... compromises receptor activity.
@en
An androgen receptor mutation ...... compromises receptor activity.
@nl
prefLabel
An androgen receptor mutation ...... compromises receptor activity.
@en
An androgen receptor mutation ...... compromises receptor activity.
@nl
P2093
P50
P356
P1476
An androgen receptor mutation ...... compromises receptor activity.
@en
P2093
Adrienne R Hanson
Grant Buchanan
Nicole L Moore
Stephen N Birrell
Theresa E Hickey
Wayne D Tilley
P304
P356
10.1530/ERC-12-0065
P4510
P577
2012-07-22T00:00:00Z